CN104489516A - 提高肿瘤患者术后免疫功能的养生粥及制法 - Google Patents
提高肿瘤患者术后免疫功能的养生粥及制法 Download PDFInfo
- Publication number
- CN104489516A CN104489516A CN201410723136.5A CN201410723136A CN104489516A CN 104489516 A CN104489516 A CN 104489516A CN 201410723136 A CN201410723136 A CN 201410723136A CN 104489516 A CN104489516 A CN 104489516A
- Authority
- CN
- China
- Prior art keywords
- parts
- health
- preserving porridge
- minute
- radix astragali
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 235000021395 porridge Nutrition 0.000 title claims abstract description 52
- 206010028980 Neoplasm Diseases 0.000 title claims abstract description 33
- 238000002360 preparation method Methods 0.000 title claims abstract description 25
- 230000002980 postoperative effect Effects 0.000 title claims abstract description 19
- 201000011510 cancer Diseases 0.000 title abstract description 14
- 230000036737 immune function Effects 0.000 title abstract description 6
- 239000003973 paint Substances 0.000 title abstract 2
- 235000000832 Ayote Nutrition 0.000 claims abstract description 43
- 235000009854 Cucurbita moschata Nutrition 0.000 claims abstract description 43
- 235000009804 Cucurbita pepo subsp pepo Nutrition 0.000 claims abstract description 43
- 241000241413 Propolis Species 0.000 claims abstract description 43
- 229940069949 propolis Drugs 0.000 claims abstract description 43
- 235000015136 pumpkin Nutrition 0.000 claims abstract description 43
- 244000062793 Sorghum vulgare Species 0.000 claims abstract description 40
- 235000019713 millet Nutrition 0.000 claims abstract description 40
- 244000241838 Lycium barbarum Species 0.000 claims abstract description 34
- 235000015459 Lycium barbarum Nutrition 0.000 claims abstract description 33
- 235000003140 Panax quinquefolius Nutrition 0.000 claims abstract description 30
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims abstract description 29
- 235000008434 ginseng Nutrition 0.000 claims abstract description 29
- 240000007049 Juglans regia Species 0.000 claims abstract description 25
- 235000009496 Juglans regia Nutrition 0.000 claims abstract description 25
- 235000020234 walnut Nutrition 0.000 claims abstract description 25
- 241000208688 Eucommia Species 0.000 claims abstract description 24
- 239000000843 powder Substances 0.000 claims abstract description 22
- 235000004879 dioscorea Nutrition 0.000 claims abstract description 21
- 235000013312 flour Nutrition 0.000 claims abstract description 21
- 239000002994 raw material Substances 0.000 claims abstract description 12
- 239000009636 Huang Qi Substances 0.000 claims description 46
- 238000009835 boiling Methods 0.000 claims description 36
- 230000036039 immunity Effects 0.000 claims description 33
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 29
- 230000008859 change Effects 0.000 claims description 28
- 239000003814 drug Substances 0.000 claims description 27
- 241001165494 Rhodiola Species 0.000 claims description 21
- 239000006228 supernatant Substances 0.000 claims description 14
- 229940079593 drug Drugs 0.000 claims description 13
- 238000000034 method Methods 0.000 claims description 13
- 240000001980 Cucurbita pepo Species 0.000 claims description 9
- 208000004104 gestational diabetes Diseases 0.000 claims description 8
- 238000002156 mixing Methods 0.000 claims description 8
- 230000002265 prevention Effects 0.000 claims description 8
- 230000008569 process Effects 0.000 claims description 8
- 240000007594 Oryza sativa Species 0.000 claims description 7
- 235000007164 Oryza sativa Nutrition 0.000 claims description 7
- 235000013339 cereals Nutrition 0.000 claims description 7
- 239000000155 melt Substances 0.000 claims description 7
- 235000009566 rice Nutrition 0.000 claims description 7
- 238000003756 stirring Methods 0.000 claims description 7
- 241000208340 Araliaceae Species 0.000 claims 5
- 230000000694 effects Effects 0.000 abstract description 33
- 235000015468 Lycium chinense Nutrition 0.000 abstract description 6
- 235000013399 edible fruits Nutrition 0.000 abstract description 6
- 231100000331 toxic Toxicity 0.000 abstract description 4
- 230000002588 toxic effect Effects 0.000 abstract description 4
- 241000219122 Cucurbita Species 0.000 abstract description 2
- 241000213006 Angelica dahurica Species 0.000 abstract 1
- 241001061264 Astragalus Species 0.000 abstract 1
- 235000010110 Astragalus glycyphyllos Nutrition 0.000 abstract 1
- 244000131316 Panax pseudoginseng Species 0.000 abstract 1
- 241001619461 Poria <basidiomycete fungus> Species 0.000 abstract 1
- 241001247821 Ziziphus Species 0.000 abstract 1
- 235000006533 astragalus Nutrition 0.000 abstract 1
- 240000004244 Cucurbita moschata Species 0.000 description 32
- 240000005373 Panax quinquefolius Species 0.000 description 24
- 238000002512 chemotherapy Methods 0.000 description 20
- 230000006870 function Effects 0.000 description 17
- 206010025482 malaise Diseases 0.000 description 14
- 238000001959 radiotherapy Methods 0.000 description 14
- 208000024891 symptom Diseases 0.000 description 14
- 210000004072 lung Anatomy 0.000 description 12
- 239000008280 blood Substances 0.000 description 9
- 210000004369 blood Anatomy 0.000 description 9
- 235000013305 food Nutrition 0.000 description 9
- 235000009508 confectionery Nutrition 0.000 description 8
- 210000003734 kidney Anatomy 0.000 description 8
- 210000004027 cell Anatomy 0.000 description 7
- 230000007812 deficiency Effects 0.000 description 7
- 210000003205 muscle Anatomy 0.000 description 7
- 210000000952 spleen Anatomy 0.000 description 7
- 210000002784 stomach Anatomy 0.000 description 7
- 235000002722 Dioscorea batatas Nutrition 0.000 description 6
- 235000006536 Dioscorea esculenta Nutrition 0.000 description 6
- 240000001811 Dioscorea oppositifolia Species 0.000 description 6
- 235000003416 Dioscorea oppositifolia Nutrition 0.000 description 6
- 206010020772 Hypertension Diseases 0.000 description 6
- 208000027418 Wounds and injury Diseases 0.000 description 6
- 230000008901 benefit Effects 0.000 description 6
- 230000006378 damage Effects 0.000 description 6
- 239000000463 material Substances 0.000 description 6
- 239000000047 product Substances 0.000 description 6
- 206010011224 Cough Diseases 0.000 description 5
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 5
- 244000241872 Lycium chinense Species 0.000 description 5
- 206010033557 Palpitations Diseases 0.000 description 5
- 230000000844 anti-bacterial effect Effects 0.000 description 5
- 201000010099 disease Diseases 0.000 description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 4
- 230000036528 appetite Effects 0.000 description 4
- 235000019789 appetite Nutrition 0.000 description 4
- 238000010438 heat treatment Methods 0.000 description 4
- 210000004185 liver Anatomy 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 231100000419 toxicity Toxicity 0.000 description 4
- 230000001988 toxicity Effects 0.000 description 4
- 210000004881 tumor cell Anatomy 0.000 description 4
- 239000011701 zinc Substances 0.000 description 4
- 229910052725 zinc Inorganic materials 0.000 description 4
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 3
- 206010012735 Diarrhoea Diseases 0.000 description 3
- 208000000059 Dyspnea Diseases 0.000 description 3
- 206010013975 Dyspnoeas Diseases 0.000 description 3
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 3
- 241000700605 Viruses Species 0.000 description 3
- 150000001413 amino acids Chemical class 0.000 description 3
- 230000017531 blood circulation Effects 0.000 description 3
- 239000010839 body fluid Substances 0.000 description 3
- 239000011575 calcium Substances 0.000 description 3
- 229910052791 calcium Inorganic materials 0.000 description 3
- 230000002950 deficient Effects 0.000 description 3
- 230000036541 health Effects 0.000 description 3
- 201000001881 impotence Diseases 0.000 description 3
- 208000014674 injury Diseases 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 210000005036 nerve Anatomy 0.000 description 3
- 235000016709 nutrition Nutrition 0.000 description 3
- 239000011574 phosphorus Substances 0.000 description 3
- 229910052698 phosphorus Inorganic materials 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 238000007086 side reaction Methods 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- 230000001954 sterilising effect Effects 0.000 description 3
- 238000005728 strengthening Methods 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- 230000001225 therapeutic effect Effects 0.000 description 3
- 230000035922 thirst Effects 0.000 description 3
- 239000011573 trace mineral Substances 0.000 description 3
- 235000013619 trace mineral Nutrition 0.000 description 3
- 235000019164 vitamin B2 Nutrition 0.000 description 3
- 239000011716 vitamin B2 Substances 0.000 description 3
- 239000011800 void material Substances 0.000 description 3
- 208000002874 Acne Vulgaris Diseases 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 description 2
- 208000017667 Chronic Disease Diseases 0.000 description 2
- 241000110637 Cuscuta chinensis Species 0.000 description 2
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 2
- 229920000855 Fucoidan Polymers 0.000 description 2
- 208000012895 Gastric disease Diseases 0.000 description 2
- 206010019233 Headaches Diseases 0.000 description 2
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 2
- 206010028813 Nausea Diseases 0.000 description 2
- 208000002193 Pain Diseases 0.000 description 2
- 208000004880 Polyuria Diseases 0.000 description 2
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 2
- 208000003251 Pruritus Diseases 0.000 description 2
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 2
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
- 208000025865 Ulcer Diseases 0.000 description 2
- 206010046788 Uterine haemorrhage Diseases 0.000 description 2
- 229930003471 Vitamin B2 Natural products 0.000 description 2
- 206010000496 acne Diseases 0.000 description 2
- 208000007502 anemia Diseases 0.000 description 2
- 230000003712 anti-aging effect Effects 0.000 description 2
- 230000001093 anti-cancer Effects 0.000 description 2
- 230000003064 anti-oxidating effect Effects 0.000 description 2
- 239000003963 antioxidant agent Substances 0.000 description 2
- 230000003078 antioxidant effect Effects 0.000 description 2
- 235000006708 antioxidants Nutrition 0.000 description 2
- 208000006673 asthma Diseases 0.000 description 2
- 210000004204 blood vessel Anatomy 0.000 description 2
- 210000001124 body fluid Anatomy 0.000 description 2
- -1 carrotene Proteins 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 229910052804 chromium Inorganic materials 0.000 description 2
- 239000011651 chromium Substances 0.000 description 2
- 230000002354 daily effect Effects 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 230000029087 digestion Effects 0.000 description 2
- 230000035619 diuresis Effects 0.000 description 2
- 208000002173 dizziness Diseases 0.000 description 2
- 201000006549 dyspepsia Diseases 0.000 description 2
- 230000003203 everyday effect Effects 0.000 description 2
- 239000000835 fiber Substances 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 239000007789 gas Substances 0.000 description 2
- 150000004676 glycans Chemical class 0.000 description 2
- 231100000869 headache Toxicity 0.000 description 2
- 230000035876 healing Effects 0.000 description 2
- 230000001631 hypertensive effect Effects 0.000 description 2
- 230000002218 hypoglycaemic effect Effects 0.000 description 2
- 206010022437 insomnia Diseases 0.000 description 2
- 229910052742 iron Inorganic materials 0.000 description 2
- 230000002147 killing effect Effects 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- 208000019423 liver disease Diseases 0.000 description 2
- 239000011777 magnesium Substances 0.000 description 2
- 229910052749 magnesium Inorganic materials 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 230000027939 micturition Effects 0.000 description 2
- 239000011259 mixed solution Substances 0.000 description 2
- 230000002107 myocardial effect Effects 0.000 description 2
- 230000008693 nausea Effects 0.000 description 2
- 231100000862 numbness Toxicity 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 230000035764 nutrition Effects 0.000 description 2
- 230000036407 pain Effects 0.000 description 2
- 239000000049 pigment Substances 0.000 description 2
- 229920001282 polysaccharide Polymers 0.000 description 2
- 239000005017 polysaccharide Substances 0.000 description 2
- 239000011591 potassium Substances 0.000 description 2
- 229910052700 potassium Inorganic materials 0.000 description 2
- 230000005855 radiation Effects 0.000 description 2
- 230000008929 regeneration Effects 0.000 description 2
- 238000011069 regeneration method Methods 0.000 description 2
- 229960002477 riboflavin Drugs 0.000 description 2
- 210000004706 scrotum Anatomy 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 238000004659 sterilization and disinfection Methods 0.000 description 2
- 230000001629 suppression Effects 0.000 description 2
- 208000011580 syndromic disease Diseases 0.000 description 2
- 231100000397 ulcer Toxicity 0.000 description 2
- 229910052720 vanadium Inorganic materials 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 150000003722 vitamin derivatives Chemical class 0.000 description 2
- 230000037303 wrinkles Effects 0.000 description 2
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- 206010000077 Abdominal mass Diseases 0.000 description 1
- 241000173529 Aconitum napellus Species 0.000 description 1
- 241000219068 Actinidia Species 0.000 description 1
- 235000001674 Agaricus brunnescens Nutrition 0.000 description 1
- 201000004384 Alopecia Diseases 0.000 description 1
- 208000000044 Amnesia Diseases 0.000 description 1
- 208000031091 Amnestic disease Diseases 0.000 description 1
- 206010002383 Angina Pectoris Diseases 0.000 description 1
- 201000001320 Atherosclerosis Diseases 0.000 description 1
- 241000132012 Atractylodes Species 0.000 description 1
- 102000040350 B family Human genes 0.000 description 1
- 108091072128 B family Proteins 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 206010070918 Bone deformity Diseases 0.000 description 1
- 206010006458 Bronchitis chronic Diseases 0.000 description 1
- 102100034279 Calcium-binding mitochondrial carrier protein Aralar2 Human genes 0.000 description 1
- 206010007247 Carbuncle Diseases 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 244000020518 Carthamus tinctorius Species 0.000 description 1
- 235000003255 Carthamus tinctorius Nutrition 0.000 description 1
- 241000522254 Cassia Species 0.000 description 1
- 241000282693 Cercopithecidae Species 0.000 description 1
- 241000282994 Cervidae Species 0.000 description 1
- 206010008909 Chronic Hepatitis Diseases 0.000 description 1
- 235000007516 Chrysanthemum Nutrition 0.000 description 1
- 244000189548 Chrysanthemum x morifolium Species 0.000 description 1
- 241000005787 Cistanche Species 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 206010012335 Dependence Diseases 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 206010013935 Dysmenorrhoea Diseases 0.000 description 1
- 206010013954 Dysphoria Diseases 0.000 description 1
- 244000286838 Eclipta prostrata Species 0.000 description 1
- 206010016654 Fibrosis Diseases 0.000 description 1
- 229940123457 Free radical scavenger Drugs 0.000 description 1
- 206010017533 Fungal infection Diseases 0.000 description 1
- 241000222336 Ganoderma Species 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 1
- 241000096284 Gynochthodes officinalis Species 0.000 description 1
- 206010019280 Heart failures Diseases 0.000 description 1
- 206010019468 Hemiplegia Diseases 0.000 description 1
- 206010019617 Henoch-Schonlein purpura Diseases 0.000 description 1
- 244000153234 Hibiscus abelmoschus Species 0.000 description 1
- 241000251511 Holothuroidea Species 0.000 description 1
- 208000031814 IgA Vasculitis Diseases 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 241001313288 Labia Species 0.000 description 1
- 241001106041 Lycium Species 0.000 description 1
- 208000037093 Menstruation Disturbances Diseases 0.000 description 1
- 206010027339 Menstruation irregular Diseases 0.000 description 1
- 208000000112 Myalgia Diseases 0.000 description 1
- 208000031888 Mycoses Diseases 0.000 description 1
- 241000158526 Nasalis Species 0.000 description 1
- IOVCWXUNBOPUCH-UHFFFAOYSA-N Nitrous acid Chemical compound ON=O IOVCWXUNBOPUCH-UHFFFAOYSA-N 0.000 description 1
- 240000002948 Ophiopogon intermedius Species 0.000 description 1
- 244000170916 Paeonia officinalis Species 0.000 description 1
- 235000006484 Paeonia officinalis Nutrition 0.000 description 1
- 206010036018 Pollakiuria Diseases 0.000 description 1
- 244000226566 Psoralea corylifolia Species 0.000 description 1
- 241000405414 Rehmannia Species 0.000 description 1
- 208000034189 Sclerosis Diseases 0.000 description 1
- 238000003457 Shi epoxidation reaction Methods 0.000 description 1
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- PJANXHGTPQOBST-VAWYXSNFSA-N Stilbene Natural products C=1C=CC=CC=1/C=C/C1=CC=CC=C1 PJANXHGTPQOBST-VAWYXSNFSA-N 0.000 description 1
- 208000009205 Tinnitus Diseases 0.000 description 1
- 241000700647 Variola virus Species 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 208000031975 Yang Deficiency Diseases 0.000 description 1
- 208000031971 Yin Deficiency Diseases 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 231100000360 alopecia Toxicity 0.000 description 1
- 230000006986 amnesia Effects 0.000 description 1
- 230000036592 analgesia Effects 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 230000000954 anitussive effect Effects 0.000 description 1
- 230000003266 anti-allergic effect Effects 0.000 description 1
- 230000001088 anti-asthma Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000001139 anti-pruritic effect Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 230000002155 anti-virotic effect Effects 0.000 description 1
- 239000003908 antipruritic agent Substances 0.000 description 1
- 229940124584 antitussives Drugs 0.000 description 1
- 239000003443 antiviral agent Substances 0.000 description 1
- 210000003056 antler Anatomy 0.000 description 1
- 230000004596 appetite loss Effects 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 206010003549 asthenia Diseases 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 210000000941 bile Anatomy 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 235000007215 black sesame Nutrition 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 210000001185 bone marrow Anatomy 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 206010006451 bronchitis Diseases 0.000 description 1
- 230000000711 cancerogenic effect Effects 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 231100000357 carcinogen Toxicity 0.000 description 1
- 239000003183 carcinogenic agent Substances 0.000 description 1
- 206010007625 cardiogenic shock Diseases 0.000 description 1
- 230000002612 cardiopulmonary effect Effects 0.000 description 1
- 230000009084 cardiovascular function Effects 0.000 description 1
- 210000000748 cardiovascular system Anatomy 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 230000000973 chemotherapeutic effect Effects 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 208000007451 chronic bronchitis Diseases 0.000 description 1
- 230000007882 cirrhosis Effects 0.000 description 1
- 208000019425 cirrhosis of liver Diseases 0.000 description 1
- 108010084210 citrin Proteins 0.000 description 1
- 239000010941 cobalt Substances 0.000 description 1
- 229910017052 cobalt Inorganic materials 0.000 description 1
- GUTLYIVDDKVIGB-UHFFFAOYSA-N cobalt atom Chemical compound [Co] GUTLYIVDDKVIGB-UHFFFAOYSA-N 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 230000001186 cumulative effect Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 238000001784 detoxification Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- ZZVUWRFHKOJYTH-UHFFFAOYSA-N diphenhydramine Chemical compound C=1C=CC=CC=1C(OCCN(C)C)C1=CC=CC=C1 ZZVUWRFHKOJYTH-UHFFFAOYSA-N 0.000 description 1
- 230000008034 disappearance Effects 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 238000003912 environmental pollution Methods 0.000 description 1
- 206010015037 epilepsy Diseases 0.000 description 1
- 230000003628 erosive effect Effects 0.000 description 1
- 210000003414 extremity Anatomy 0.000 description 1
- 230000035558 fertility Effects 0.000 description 1
- 230000001605 fetal effect Effects 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 239000003292 glue Substances 0.000 description 1
- 230000036449 good health Effects 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
- 208000013403 hyperactivity Diseases 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 208000015446 immunoglobulin a vasculitis Diseases 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- 230000003907 kidney function Effects 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 201000005630 leukorrhea Diseases 0.000 description 1
- 230000005976 liver dysfunction Effects 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 208000019017 loss of appetite Diseases 0.000 description 1
- 235000021266 loss of appetite Nutrition 0.000 description 1
- 239000006210 lotion Substances 0.000 description 1
- 210000003141 lower extremity Anatomy 0.000 description 1
- 235000012680 lutein Nutrition 0.000 description 1
- 239000001656 lutein Substances 0.000 description 1
- KBPHJBAIARWVSC-RGZFRNHPSA-N lutein Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\[C@H]1C(C)=C[C@H](O)CC1(C)C KBPHJBAIARWVSC-RGZFRNHPSA-N 0.000 description 1
- 229960005375 lutein Drugs 0.000 description 1
- ORAKUVXRZWMARG-WZLJTJAWSA-N lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C ORAKUVXRZWMARG-WZLJTJAWSA-N 0.000 description 1
- 210000001165 lymph node Anatomy 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 230000004089 microcirculation Effects 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 239000002366 mineral element Substances 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- 230000003387 muscular Effects 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- 239000002547 new drug Substances 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 150000002926 oxygen Chemical class 0.000 description 1
- 244000045947 parasite Species 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 210000002640 perineum Anatomy 0.000 description 1
- 230000008855 peristalsis Effects 0.000 description 1
- 210000003800 pharynx Anatomy 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 238000003825 pressing Methods 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 239000002516 radical scavenger Substances 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 210000004994 reproductive system Anatomy 0.000 description 1
- 206010039083 rhinitis Diseases 0.000 description 1
- 235000019991 rice wine Nutrition 0.000 description 1
- 231100000241 scar Toxicity 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 230000035939 shock Effects 0.000 description 1
- 208000013220 shortness of breath Diseases 0.000 description 1
- 239000010703 silicon Substances 0.000 description 1
- 229910052710 silicon Inorganic materials 0.000 description 1
- 208000017520 skin disease Diseases 0.000 description 1
- 230000000391 smoking effect Effects 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 235000015096 spirit Nutrition 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 208000010110 spontaneous platelet aggregation Diseases 0.000 description 1
- 206010041823 squamous cell carcinoma Diseases 0.000 description 1
- PJANXHGTPQOBST-UHFFFAOYSA-N stilbene Chemical compound C=1C=CC=CC=1C=CC1=CC=CC=C1 PJANXHGTPQOBST-UHFFFAOYSA-N 0.000 description 1
- 235000021286 stilbenes Nutrition 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 230000035882 stress Effects 0.000 description 1
- 210000004003 subcutaneous fat Anatomy 0.000 description 1
- 238000007910 systemic administration Methods 0.000 description 1
- 231100000886 tinnitus Toxicity 0.000 description 1
- KBPHJBAIARWVSC-XQIHNALSSA-N trans-lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C KBPHJBAIARWVSC-XQIHNALSSA-N 0.000 description 1
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 1
- 230000002485 urinary effect Effects 0.000 description 1
- 206010046901 vaginal discharge Diseases 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 238000003466 welding Methods 0.000 description 1
- FJHBOVDFOQMZRV-XQIHNALSSA-N xanthophyll Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C=C(C)C(O)CC2(C)C FJHBOVDFOQMZRV-XQIHNALSSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/42—Cucurbitaceae (Cucumber family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/63—Arthropods
- A61K35/64—Insects, e.g. bees, wasps or fleas
- A61K35/644—Beeswax; Propolis; Royal jelly; Honey
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
- A61K36/076—Poria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/41—Crassulaceae (Stonecrop family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/46—Eucommiaceae (Eucommia family), e.g. hardy rubber tree
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/481—Astragalus (milkvetch)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/52—Juglandaceae (Walnut family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/72—Rhamnaceae (Buckthorn family), e.g. buckthorn, chewstick or umbrella-tree
- A61K36/725—Ziziphus, e.g. jujube
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/81—Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
- A61K36/815—Lycium (desert-thorn)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/894—Dioscoreaceae (Yam family)
- A61K36/8945—Dioscorea, e.g. yam, Chinese yam or water yam
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Alternative & Traditional Medicine (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Insects & Arthropods (AREA)
- Animal Husbandry (AREA)
- Zoology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明公开了一种提高肿瘤患者术后免疫功能的养生粥及制法,取下述重量配比的主要原料制备而成:南瓜8-16份,当归3-12份,黄芪6-12份,茯神1-5份,大枣6-14份,小米20-35份,人参6-15份,核桃粉6-15份,杜仲6-12份,蜂胶3-6份,枸杞2-8份,红景天3-9份,山药粉5-9份。本发明养生粥疗效确切且无任何毒副作用,能提高患者的免疫功能。
Description
技术领域
本发明涉及中医中药领域,尤其是涉及一种提高肿瘤患者术后免疫功能的养生粥及制法。
背景技术
肿瘤,尤其是恶性肿瘤严重影响人的生命和健康,对于恶性肿瘤,一般采用手术治疗、放射性治疗和化学药物治疗。放射治疗,是用各种不同能量的射线照射肿瘤,以抑制和杀灭癌细胞的一种治疗方法。化疗,是用化学物质来治疗恶性肿瘤,化疗药物以全身给药,会攻击身体的所有细胞,而不仅仅是癌细胞。一些化疗药物被单独用于治疗癌症,但往往是几种药物联合治疗。
由于化疗是利用化学药物杀死肿瘤细胞、抑制肿瘤细胞的生长繁殖和促进肿瘤细胞的分化,大剂量的化学药物在杀伤肿瘤细胞的同时,也将正常的细胞和免疫(抵抗)细胞一同杀灭,是一种“玉石俱焚”的治疗方法。放、化疗在治疗肿瘤的同时,也会对人体产生的副作用,降低人体的免疫力。这些毒副作用主要表现为,恶心呕吐、脱发、食欲不振、头痛和肌肉疼痛、全身乏力、骨髓抑制、贫血、血小板减少、肺损伤、生殖系统损伤、肾和泌尿系统损伤、肝功能损伤等。这些副作用严重影响了放、化疗的治疗效果,甚至被迫停止治疗。
恶性肿瘤属于中医“积”、“虚劳”的范畴,存在着正虚邪实的表现。并且由于病程的绵延,会导致“久病及肾”的现象。在接受放、化疗之后,其正虚症候更加明显,因元气进一步受损可致:精神萎靡、全身乏力、五心烦热、少言懒语等。伤于胃则恶心纳呆,伤于肾则头晕耳鸣,齿落发脱,腰酸足软,伤于心则心悸气短。因此,减轻放、化疗的毒副作用,提高患者的免疫力,使患者可以更好的接受治疗,具有很重要的意义。
中医药在改善这些反应、提高患者的免疫力方面有明显的优势,但是真正开发成的新药并不是很多。本发明养生粥是在查阅了大量的中医文献资料和大量临床试验的基础上,针对放、化疗产生的毒副反应以及降低患者免疫力的主要中医病机,在治疗由放、化疗长生的毒副反应的同时,还能提高患者的免疫力,增强患者的体质,使患者能够更好的接受治疗,避免产生因放、化疗的副反应而停止治疗的现象。
申请公布号为CN103272116A(申请号201310197270.1)的中国专利文献公开了一种名为“用于放疗期间调整身体免疫力的药物”,该药物是由黄芪40~60、当归5~15、麦冬10~30、西洋参1~3、山茱萸5~15、枸杞子5~15、玄参5~15、菊花5-10、红花5~10、猴菇菌30~60、藤梨根30~60、黑芝10-15、菟丝子15~25、补骨脂5~15、黄芪15~25、墨旱莲15~25、炒白术15~25、山药15~25组成。申请公布号为CN101926429A(申请号201010239490.2)的中国专利文献公开了一种名为“可增强化疗期间免疫力的营养液及制备方法”,该营养液由固形物含量为均为2%-20%的鲍鱼多糖和岩藻聚糖硫酸酯的混合溶液,按照鲍鱼多糖5-50mg/100ml,岩藻聚糖硫酸酯100-1000mg/100ml的配比混合,并在混合溶液中加入陈皮煮沸制成的。申请公布号为CN102327390A(申请号201110314905.2)的中国专利文献公开了一种名为“一种防治化疗毒副反应的中药组方及其丸剂的制备方法”,其由阿胶、人参、肉桂、核桃粉、熟地黄、杜仲、白术、黄芪、当归、白芍、菟丝子、枸杞子、当归、陈皮、灵芝、肉苁蓉、鹿茸、麝香、钟乳石、巴戟天、附子、海参、甘草、鹿角胶、黄酒按照一定的重量配比组成。
总之,中医药在治疗放、化疗副反应方面取得了一定的成效,但也存在一些问题:临床上对提高患者的免疫力方面的治疗效果还不够理想;一些配方药材众多,且药材成本较高,不适宜大多数人服用,因此需要进一步完善。
发明内容
针对现有技术的不足,本发明的目的之一在于提供一种制备简单、服用方便、无副作用的养生粥,对放、化疗引起的毒副反应有很好的治疗效果,能提高患者的免疫功能。
本发明的另一目的就是提供上述养生粥的制备方法。
本发明的技术方案是:
提高肿瘤患者术后免疫功能的养生粥,取下述重量配比的主要原料制备而成:南瓜8-16份,当归3-12份,黄芪6-12份,茯神1-5份,大枣6-14份,小米20-35份,人参6-15份,核桃粉6-15份,杜仲6-12份,蜂胶3-6份,枸杞2-8份,红景天3-9份,山药粉5-9份。
提高肿瘤患者术后免疫功能的养生粥,优选的方案为,取下述重量配比的主要原料制备而成:南瓜10-14份,当归5-9份,黄芪8-10份,茯神2-4份,大枣8-12份,小米25-30份,人参9-12份,核桃粉9-13份,杜仲8-10份,蜂胶3-5份,枸杞4-6份,红景天5-7份,山药粉6-8份。
提高肿瘤患者术后免疫功能的养生粥,更加优选的方案为,取下述重量配比的主要原料制备而成:南瓜12份,当归7份,黄芪9份,茯神3份,大枣10份,小米28份,人参10份,核桃粉11份,杜仲9份,蜂胶4份,枸杞5份,红景天6份,山药粉7份。
所述提高肿瘤患者术后免疫功能的养生粥的制备方法,步骤如下:
(1)将小米、黄芪、大枣和枸杞洗净,置于电饭锅内,加小米、黄芪、大枣和枸杞总重量1-3倍的水,浸泡20-40分钟后,将黄芪取出;
(2)将人参洗净,沥干水分,切成大米粒大小的块;
(3)将南瓜洗净,去籽,切成硬币大小的块;
(4)将当归、茯神、杜仲和红景天置于砂锅内,加原料药总重量2-4倍的热水,于无烟的炉火上迅速加热至沸腾,待持续沸腾5-15分钟后,改小火煎煮20-40分钟,停火前盖上盖子,稍焖3-5分钟,静置60-120分钟,取上清液待用;
(5)将步骤(3)所得南瓜块置于步骤(1)所得物中,大火煎煮至沸腾后改小火煎煮10-20分钟,在煎煮的过程中,一边煎煮一边搅拌,将南瓜搅碎,与小米混合均匀后加入步骤(2)所得人参和步骤(4)所得上清液,大火迅速加热至沸腾后,再加入蜂胶,待蜂胶完全融化后,在煎煮1-3分钟后加入核桃粉和山药粉,改小火慢煨3-8分钟,停火即得养生粥。
上述养生粥的制备方法,步骤(1)加小米、黄芪、大枣和枸杞总重量1.5-2.5倍的水(优选的,加小米、黄芪、大枣和枸杞总重量2倍的水)。
上述养生粥的制备方法,步骤(1)浸泡25-35分钟后,将黄芪取出(优选的,浸泡30分钟后,将黄芪取出)。
上述预防妊娠期糖尿病的养生粥的制备方法,步骤(4)加原料药总重量2.5-3.5倍的热水(优选的,加原料药总重量3倍的热水)。
上述预防妊娠期糖尿病的养生粥的制备方法,步骤(4)待持续沸腾8-13分钟后,改小火煎煮25-35分钟(优选的,待持续沸腾10分钟后,改小火煎煮30分钟)。
上述预防妊娠期糖尿病的养生粥的制备方法,步骤(4)停火前盖上盖子,稍焖3.5-4.5分钟,静置80-100分钟(优选的,停火前盖上盖子,稍焖4分钟,静置90分钟)。
上述预防妊娠期糖尿病的养生粥的制备方法,步骤(5)大火煎煮至沸腾后改小火煎煮13-18分钟(优选的,大火煎煮至沸腾后改小火煎煮15分钟)。
本发明所用主要中药原料的药理如下:
南瓜:南瓜不仅有较高的食用价值,而且有着不可忽视的食疗作用。据《滇南本草》载:南瓜性温,味甘无毒,入脾、胃二经,能润肺益气,化痰排脓,驱虫解毒,治咳止喘,疗肺痈便秘,并有利尿、美容等作用。南瓜分泌的胆汁可以促进肠胃蠕动,帮助食物消化,同时其中的果胶可以让人免受粗糙食品的刺激,保护我们的胃胶道粘膜。另外南瓜可以使肝、肾功能得到恢复以及再生的能力,因为南瓜可以消除致癌物质亚硝酸的突变作用。南瓜中还有一种“钴”的成分,食用后有补血作用。南瓜含有丰富的维生素A、b、c及矿物质,必需的8种氨基酸和儿童必需的组氨酸,可溶性纤维、叶黄素和磷、钾、钙、镁、锌、硅等微量元素。近代营养学和医学表明,多食南瓜可有效防治高血压,糖尿病及肝脏病变,提高人体免疫能力。
当归:当归别名干归、秦哪、西当归、岷当归、金当归、当归身、涵归尾、当归曲、土当归,多年生草本,补血;活血;调经止痛;润燥滑肠。主血虚诸证;月经不调;经闭;痛经;症瘕结聚;崩漏;虚寒腹痛;痿痹;肌肤麻木;肠燥便难;赤痢后重;痈疽疮疡;跌扑损伤。
黄芪:黄芪,又名绵芪。其有增强机体免疫功能、保肝、利尿、抗衰老、抗应激、降压和较广泛的抗菌作用。但表实邪盛,气滞湿阻,食积停滞,痈疽初起或溃后热毒尚盛等实证,以及阴虚阳亢者。
茯神:性味:味甘,淡,平。归经:归心、肺经。功效:宁心,安神,利水。主治:心虚惊悸,健忘,失眠,惊痫,小便不利。
大枣:红枣富含蛋白质、脂肪、糖类、胡萝卜素、B族维生素、维生素C、维生素P以及钙、磷、铁和环磷酸腺苷等营养成分。其中维生素C的含量在果品中名列前茅,有维生素王之美称,具有补血养颜之功效。红枣所含有的环磷酸腺苷,是人体细胞能量代谢的必需成分,能够增强肌力、消除疲劳、扩张血管、增加心肌收缩力、改善心肌营养,对防治心血管系统疾病有良好的作用;中医中药理论认为,红枣具有补虚益气、养血安神、健脾和胃等作用,红枣对慢性肝炎、肝硬化、贫血、过敏性紫癜等病症有较好疗效;红枣含有三萜类化合物及环磷酸腺苷,有较强的抗癌、抗过敏作用。大枣能润心肺、止咳、补五脏、治虚损、除肠胃癖气,还能安中养脾、平胃气、通九窍、助十二经等。
小米:健脾和胃、补益虚损、和中益肾、除热解毒。治脾胃虚热、反胃呕吐、消渴、泄泻。小米中所含的维生素B2,能防止男性阴囊皮肤出现渗液、糜烂、脱屑等现象;防止女性会阴瘙痒、阴唇皮炎和白带过多。妊娠期妇女补充维生素B2,能避免胎儿骨骼畸形。保持人体所需的维生素B2,能维持生长和生殖力正常。
人参:味甘、微苦,性温、平。归脾、肺经、心经。补气,固脱,生津,安神,益智。体虚欲脱,肢冷脉微,脾虚食少,肺虚喘咳,津伤口渴,内热消渴,久病虚羸,惊悸失眠,阳痿宫冷;心力衰竭,心原性休克。用于气短喘促,心悸健忘,口渴多汗,食少无力,一切急慢性疾病及失血后引起的休克、虚脱。大补元气,固脱生津,安神。治劳伤虚损,食少,倦怠,反胃吐食,大便滑泄,虚咳喘促,自汗暴脱,惊悸,健忘,眩晕头痛,阳痿,尿频,消渴,妇女崩漏,小儿慢惊,及久虚不复,一切气血津液不足之证。
核桃粉:有防治动脉硬化的功效。核桃仁中含有锌、锰、铬等人体不可缺少的微量元素。人体在衰老过程中锌、锰含量日渐降低,铬有促进葡萄糖利用、胆固醇代谢和保护心血管的功能。核桃仁的镇咳平喘作用也十分明显,冬季,对慢性气管炎和哮喘病患者疗效极佳。可见经常食用核桃,既能健身体,又能抗衰老。
杜仲:杜仲游离氨基酸极少,含有的少量蛋白质,是和绝大多数食品类似的完全蛋白,即能够水解检出对人体必需的8种氨基酸。测定了杜仲所含的15种矿物元素,其中有锌、铜、铁等微量元素,及钙、磷、钾、镁等宏量元素。其味甘,性温。有补益肝肾、强筋壮骨、调理冲任、固经安胎的功效。可治疗肾阳虚引起的腰腿痛或酸软无力,肝气虚引起的胞胎不固,阴囊湿痒等症。
蜂胶:蜂胶:具有的抗菌、美容养颜、促进细胞再生的这就注定了蜂胶在护肤品行业的重要地位,它不但能消灭真菌感染,还能够分解色素、平复皱纹、减缓衰老,加快组织细胞的再生和伤口的愈合,对痘痘遗留下的痘疤痘印也有很好疗效。近代研究证明,蜂胶所含有的丰富而独特的生物活性物质,使其具有抗菌、消炎、止痒、抗氧化、增强免疫、降血糖、降血脂、抗肿瘤等多种功能,对人体有着广泛的医疗、保健作用,现已成为各国科学研究的热点,并成为新兴的保健品倍受推崇。抗菌作用。蜂胶能灭菌、杀菌、消毒、抑菌、防霉、防腐,解决了抗生素只对单一微生物起作用的缺陷,且没有副作用。在日常生活中对皮肤病有很好的治疗效果。抗病毒作用。蜂胶是天然的抗病毒物质,对多种病毒都有很强的抑制和杀灭作用。抗氧化作用。蜂胶被称为抗氧化剂和自由基清除剂,能够有效清除因肥胖、过度劳累、环境污染、吸烟等不良生活习惯和外界因素产生的过剩活性氧和自由基等废物。增强免疫力作用。人体的免疫系统容易被病毒侵害,蜂胶能够增强人体免疫力,增强人体抵抗病毒侵害的能力。抗癌作用。国内外大量的研究表明,蜂胶在抑癌抗癌方面有很好的效果。促进细胞再生作用。蜂胶能够加快组织再生和伤口的愈合。美容养颜作用。蜂胶能够分解色素、平复皱纹、减缓衰老等,是女性美容佳品。镇痛作用。蜂胶在麻醉镇痛方面也有很好的效果。预防肿瘤。蜂胶中含有丰富的抗癌物质,研究证明,癌症患者在服用蜂胶后,可缩小癌细胞且能减轻化疗、放疗引起的副作用。抗高血压。患有高血压的患者连续服用含非常多的黄酮类物质及具有非常强抗氧化能力的蜂胶,不仅可以减少过氧化脂质对血管的危害,防止血管硬化,而且还能有效地降低甘油三脂的含量,减少血小板聚集,改善微循环,可以降低过高的血压,防止意外事情的发生。因而,中老年人,特别是高血压、心脏病、动脉硬化病人,常常服用蜂胶,对健康长寿颇有裨益。
枸杞:枸杞是人们对商品枸杞子、植物宁夏枸杞、中华枸杞等枸杞属下物种的统称。甘,平。枸杞叶:苦、甘;性凉。功能:枸杞子:养肝,滋肾,润肺。枸杞叶:补虚益精,清热明目。
红景天:味甘、苦,性平。归肺、心经。中药名。为景天科大花红景天的干燥根和根茎,秋季花茎凋枯后采挖,除去粗皮,洗净,晒干。味甘、苦,性平,归肺、心经。具有益气活血,通脉平喘之功。主要用于气虚血瘀,胸痹心痛,中风偏瘫,倦怠气喘。
山药粉:山药有“神仙之食”的美名。山药最大的特点是能防止心血管系统脂肪沉淀,保持血管的弹性,防止动脉粥样硬化过早发生,减少皮下脂肪沉积。中医认为山药具有健脾、补肺、固肾、益精等多种功效。并且对肺虚咳嗽、脾虚泄泻、肾虚遗精、带下及小便频繁等症,都有一定的疗补作用。山药健脾、除湿、补气、益肺、固肾、益精的功效,山药含有可溶性纤维,能推迟胃内食物的排空,控制饭后血糖升高。还能助消化、降血糖。
本发明提供的养生粥组方科学,各种剂型的制备方法简单,使得所得产品服用方便、便于携带。除此之外,本发明的优良效果还表现在:
1.本组方完全符合中医药原则和肿瘤病人的身心特点,能有效的提高肿瘤患者术后免疫功能。
2.所选材料皆为传统中药材,无任何毒副作用。
3.药源易得,药材成本低廉,能减轻肿瘤患者的经济负担。
具体实施方式
下面结合实施例和实验例详细说明本发明的技术方案,但保护范围不限于此。
实施例1提高肿瘤患者术后免疫功能的养生粥,取下述重量配比的主要原料制备而成(每份取10g):南瓜8份,当归3份,黄芪6份,茯神1份,大枣6份,小米20份,人参6份,核桃粉6份,杜仲6份,蜂胶3份,枸杞2份,红景天3份,山药粉5份。
上述养生粥的制备方法为:
(1)将小米、黄芪、大枣和枸杞洗净,置于电饭锅内,加小米、黄芪、大枣和枸杞总重量1倍的水,浸泡20分钟后,将黄芪取出;
(2)将人参洗净,沥干水分,切成大米粒大小的块;
(3)将南瓜洗净,去籽,切成硬币大小的块;
(4)将当归、茯神、杜仲和红景天置于砂锅内,加原料药总重量2倍的热水,于无烟的炉火上迅速加热至沸腾,待持续沸腾5分钟后,改小火煎煮20分钟,停火前盖上盖子,稍焖3分钟,静置60分钟,取上清液待用;
(5)将步骤(3)所得南瓜块置于步骤(1)所得物中,大火煎煮至沸腾后改小火煎煮10分钟,在煎煮的过程中,一边煎煮一边搅拌,将南瓜搅碎,与小米混合均匀后加入步骤(2)所得人参和步骤(4)所得上清液,大火迅速加热至沸腾后,再加入蜂胶,待蜂胶完全融化后,在煎煮1分钟后加入核桃粉和山药粉,改小火慢煨3分钟,停火即得养生粥。
典型病例一朱XX,年龄:48岁,性别:男。2006年6月患鼻炎鳞癌双颈部淋巴结转移,定期通过放、化疗进行治疗。放、化疗引起一些毒副反应:免疫功能下降、恶心呕吐、食欲不振、口干舌燥、全身乏力等。
服用实施例1所得养生粥,采用每日3次,每次300ml,加热后服用,可根据自己的口服加一些白糖,10天一个疗程。服用10天,患者口干舌燥症状减轻,食欲渐增;服用1个月,患者不适症状逐渐消失,免疫功能提高;继续服用2个月,患者自感无不适症状。
实施例2提高肿瘤患者术后免疫功能的养生粥,取下述重量配比的主要原料制备而成(每份取20g):南瓜16份,当归12份,黄芪12份,茯神5份,大枣14份,小米35份,人参15份,核桃粉15份,杜仲12份,蜂胶6份,枸杞8份,红景天9份,山药粉9份。
上述养生粥的制备方法为:
(1)将小米、黄芪、大枣和枸杞洗净,置于电饭锅内,加小米、黄芪、大枣和枸杞总重量3倍的水,浸泡40分钟后,将黄芪取出;
(2)将人参洗净,沥干水分,切成大米粒大小的块;
(3)将南瓜洗净,去籽,切成硬币大小的块;
(4)将当归、茯神、杜仲和红景天置于砂锅内,加原料药总重量4倍的热水,于无烟的炉火上迅速加热至沸腾,待持续沸腾15分钟后,改小火煎煮40分钟,停火前盖上盖子,稍焖5分钟,静置120分钟,取上清液待用;
(5)将步骤(3)所得南瓜块置于步骤(1)所得物中,大火煎煮至沸腾后改小火煎煮20分钟,在煎煮的过程中,一边煎煮一边搅拌,将南瓜搅碎,与小米混合均匀后加入步骤(2)所得人参和步骤(4)所得上清液,大火迅速加热至沸腾后,再加入蜂胶,待蜂胶完全融化后,在煎煮3分钟后加入核桃粉和山药粉,改小火慢煨8分钟,停火即得养生粥。
实施例3提高肿瘤患者术后免疫功能的养生粥,取下述重量配比的主要原料制备而成(每份30g):南瓜10份,当归5份,黄芪8份,茯神2份,大枣8份,小米25份,人参9份,核桃粉9份,杜仲8份,蜂胶3份,枸杞4份,红景天5份,山药粉6份。
上述养生粥颗的制备方法为:
(1)将小米、黄芪、大枣和枸杞洗净,置于电饭锅内,加小米、黄芪、大枣和枸杞总重量1.5倍的水,浸泡25分钟后,将黄芪取出;
(2)将人参洗净,沥干水分,切成大米粒大小的块;
(3)将南瓜洗净,去籽,切成硬币大小的块;
(4)将当归、茯神、杜仲和红景天置于砂锅内,加原料药总重量2.5倍的热水,于无烟的炉火上迅速加热至沸腾,待持续沸腾8分钟后,改小火煎煮25分钟,停火前盖上盖子,稍焖3.5分钟,静置80分钟,取上清液待用;
(5)将步骤(3)所得南瓜块置于步骤(1)所得物中,大火煎煮至沸腾后改小火煎煮13分钟,在煎煮的过程中,一边煎煮一边搅拌,将南瓜搅碎,与小米混合均匀后加入步骤(2)所得人参和步骤(4)所得上清液,大火迅速加热至沸腾后,再加入蜂胶,待蜂胶完全融化后,在煎煮1.5分钟后加入核桃粉和山药粉,改小火慢煨4分钟,停火即得养生粥。
实施例4提高肿瘤患者术后免疫功能的养生粥,取下述重量配比的主要原料制备而成(每份40g):南瓜14份,当归9份,黄芪10份,茯神4份,大枣12份,小米30份,人参12份,核桃粉13份,杜仲10份,蜂胶5份,枸杞6份,红景天7份,山药粉8份。
上述养生粥的制备方法为:
(1)将小米、黄芪、大枣和枸杞洗净,置于电饭锅内,加小米、黄芪、大枣和枸杞总重量2.5倍的水,浸泡35分钟后,将黄芪取出;
(2)将人参洗净,沥干水分,切成大米粒大小的块;
(3)将南瓜洗净,去籽,切成硬币大小的块;
(4)将当归、茯神、杜仲和红景天置于砂锅内,加原料药总重量3.5倍的热水,于无烟的炉火上迅速加热至沸腾,待持续沸腾13分钟后,改小火煎煮35分钟,停火前盖上盖子,稍焖4.5分钟,静置100分钟,取上清液待用;
(5)将步骤(3)所得南瓜块置于步骤(1)所得物中,大火煎煮至沸腾后改小火煎煮18分钟,在煎煮的过程中,一边煎煮一边搅拌,将南瓜搅碎,与小米混合均匀后加入步骤(2)所得人参和步骤(4)所得上清液,大火迅速加热至沸腾后,再加入蜂胶,待蜂胶完全融化后,在煎煮2.5分钟后加入核桃粉和山药粉,改小火慢煨7分钟,停火即得养生粥。
典型病例二邹XX,年龄:55岁,性别:女。患者因患鼻咽部低分化鳞癌,2009年6月开始化疗,化疗之后出现发热,口干,虚弱乏力,食欲低下,免疫力下降等不适症状,现消瘦异常,服用抗化疗副反应药物,均不见效。
服用实施例4所得养生粥,采用每日3次,每次400ml,加热后服用,10天一个疗程。服用10天,患者不适症状减轻;服用1个半月,患者免疫力增强,体力增强,不适症状逐渐消失;继续服用10天,患者自感痊愈。
实施例5提高肿瘤患者术后免疫功能的养生粥,取下述重量配比的主要原料制备而成(每份50g):南瓜12份,当归7份,黄芪9份,茯神3份,大枣10份,小米28份,人参10份,核桃粉11份,杜仲9份,蜂胶4份,枸杞5份,红景天6份,山药粉7份。
上述养生粥的制备方法为:
(1)将小米、黄芪、大枣和枸杞洗净,置于电饭锅内,加小米、黄芪、大枣和枸杞总重量2倍的水,浸泡30分钟后,将黄芪取出;
(2)将人参洗净,沥干水分,切成大米粒大小的块;
(3)将南瓜洗净,去籽,切成硬币大小的块;
(4)将当归、茯神、杜仲和红景天置于砂锅内,加原料药总重量3倍的热水,于无烟的炉火上迅速加热至沸腾,待持续沸腾10分钟后,改小火煎煮30分钟,停火前盖上盖子,稍焖4分钟,静置90分钟,取上清液待用;
(5)将步骤(3)所得南瓜块置于步骤(1)所得物中,大火煎煮至沸腾后改小火煎煮15分钟,在煎煮的过程中,一边煎煮一边搅拌,将南瓜搅碎,与小米混合均匀后加入步骤(2)所得人参和步骤(4)所得上清液,大火迅速加热至沸腾后,再加入蜂胶,待蜂胶完全融化后,在煎煮2分钟后加入核桃粉和山药粉,改小火慢煨5分钟,停火即得养生粥。
试验例1实施例5所得养生粥的临床应用:在6所医院筛选400例患者,其中女性200例,男性200例。试验之前1周,对该人群进行连续观察,记录症状及变化,随机分为两组,实验组及对照组,实验组服用实施例6所得产品,对照组服用其它药品(康泰安口服液、圣液口服液等常规药品)。使用方法为:每日服用三次,加热后饮用,每次300ml-500ml(视具体情况有所调整),可根据自己的口服适当的加一些白糖,10天一个疗程。疗效情况判定标准:治愈:服用本品后,不适症状消失,精力及体力明显增强;有效:服用后,不适症状减轻或部分消失,精力及体力增强;无效:服用本品后,不适症状无变化。结果如表1所示。
表1:服用实施例5所得产品治疗效果验证
服用期间自感症状及其体力精神变化如表2所示。
表2:
本发明选择南瓜、当归、黄芪、茯神、大枣、小米、人参、核桃粉、杜仲、蜂胶、枸杞、红景天和山药粉进行配伍,使药物产生协同作用,能更有效的治疗放、化疗副反应,提高患者的免疫力。服用20天,53%以上的患者免疫力增强、不适症状有所好转;服用40天,74%以上的患者感到有所好转,不适症状改善或消失,精神、体力增强;服用60天,95%以上的感到有所好转,免疫力明显增强,不适症状改善或消失,精神、体力增强,部分患者自感痊愈。实验组中服用30天以上,有效率可达95%,而对照组仅为75%。有效率高达99%,而对照组仅为65%。本发明对提高肿瘤患者术后免疫功能有特殊的疗效。
Claims (10)
1.提高肿瘤患者术后免疫功能的养生粥,其特征在于:取下述重量配比的主要原料制备而成:南瓜8-16份,当归3-12份,黄芪6-12份,茯神1-5份,大枣6-14份,小米20-35份,人参6-15份,核桃粉6-15份,杜仲6-12份,蜂胶3-6份,枸杞2-8份,红景天3-9份,山药粉5-9份。
2.根据权利要求1所述的提高肿瘤患者术后免疫功能的养生粥,其特征在于:取下述重量配比的主要原料制备而成:南瓜10-14份,当归5-9份,黄芪8-10份,茯神2-4份,大枣8-12份,小米25-30份,人参9-12份,核桃粉9-13份,杜仲8-10份,蜂胶3-5份,枸杞4-6份,红景天5-7份,山药粉6-8份。
3.根据权利要求1所述的提高肿瘤患者术后免疫功能的养生粥,其特征在于:取下述重量配比的主要原料制备而成:南瓜12份,当归7份,黄芪9份,茯神3份,大枣10份,小米28份,人参10份,核桃粉11份,杜仲9份,蜂胶4份,枸杞5份,红景天6份,山药粉7份。
4.根据权利要求1-3任一项所述的提高肿瘤患者术后免疫功能的养生粥的制备方法,其特征在于:步骤如下:
(1)将小米、黄芪、大枣和枸杞洗净,置于电饭锅内,加小米、黄芪、大枣和枸杞总重量1-3倍的水,浸泡20-40分钟后,将黄芪取出;
(2)将人参洗净,沥干水分,切成大米粒大小的块;
(3)将南瓜洗净,去籽,切成硬币大小的块;
(4)将当归、茯神、杜仲和红景天置于砂锅内,加原料药总重量2-4倍的热水,于无烟的炉火上迅速加热至沸腾,待持续沸腾5-15分钟后,改小火煎煮20-40分钟,停火前盖上盖子,稍焖3-5分钟,静置60-120分钟,取上清液待用;
(5)将步骤(3)所得南瓜块置于步骤(1)所得物中,大火煎煮至沸腾后改小火煎煮10-20分钟,在煎煮的过程中,一边煎煮一边搅拌,将南瓜搅碎,与小米混合均匀后加入步骤(2)所得人参和步骤(4)所得上清液,大火迅速加热至沸腾后,再加入蜂胶,待蜂胶完全融化后,在煎煮1-3分钟后加入核桃粉和山药粉,改小火慢煨3-8分钟,停火即得养生粥。
5.根据权利要求4所述的养生粥的制备方法,其特征在于:步骤(1)加小米、黄芪、大枣和枸杞总重量1.5-2.5倍的水(优选的,加小米、黄芪、大枣和枸杞总重量2倍的水)。
6.根据权利要求4所述的养生粥的制备方法,其特征在于:步骤(1)浸泡25-35分钟后,将黄芪取出(优选的,浸泡30分钟后,将黄芪取出)。
7.根据权利要求4所述的预防妊娠期糖尿病的养生粥的制备方法,其特征在于:步骤(4)加原料药总重量2.5-3.5倍的热水(优选的,加原料药总重量3倍的热水)。
8.根据权利要求4所述的预防妊娠期糖尿病的养生粥的制备方法,其特征在于:步骤(4)待持续沸腾8-13分钟后,改小火煎煮25-35分钟(优选的,待持续沸腾10分钟后,改小火煎煮30分钟)。
9.根据权利要求4所述的预防妊娠期糖尿病的养生粥的制备方法,其特征在于:步骤(4)停火前盖上盖子,稍焖3.5-4.5分钟,静置80-100分钟(优选的,停火前盖上盖子,稍焖4分钟,静置90分钟)。
10.根据权利要求4所述的预防妊娠期糖尿病的养生粥的制备方法,其特征在于:步骤(5)大火煎煮至沸腾后改小火煎煮13-18分钟(优选的,大火煎煮至沸腾后改小火煎煮15分钟)。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410723136.5A CN104489516A (zh) | 2014-12-03 | 2014-12-03 | 提高肿瘤患者术后免疫功能的养生粥及制法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410723136.5A CN104489516A (zh) | 2014-12-03 | 2014-12-03 | 提高肿瘤患者术后免疫功能的养生粥及制法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN104489516A true CN104489516A (zh) | 2015-04-08 |
Family
ID=52931049
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410723136.5A Pending CN104489516A (zh) | 2014-12-03 | 2014-12-03 | 提高肿瘤患者术后免疫功能的养生粥及制法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104489516A (zh) |
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104825864A (zh) * | 2015-04-27 | 2015-08-12 | 陶俊荣 | 对放疗具有增效作用的保健药膳及制备方法 |
CN104872518A (zh) * | 2015-05-27 | 2015-09-02 | 济南方宇文化传媒有限公司 | 调理胃肠功能紊乱的粥品及其制备方法 |
CN104996526A (zh) * | 2015-08-06 | 2015-10-28 | 王永卿 | 适宜胃癌患者手术后服用的糕点及其制备方法 |
CN105053800A (zh) * | 2015-08-06 | 2015-11-18 | 王永卿 | 预防肿瘤放疗引起的骨髓抑制的养生粥及其制备方法 |
CN105106712A (zh) * | 2015-09-17 | 2015-12-02 | 王守花 | 一种帮助癌症患者术后恢复的营养粥及其制备方法 |
CN105105246A (zh) * | 2015-10-09 | 2015-12-02 | 张晓林 | 一种助于产妇补气养血的饮品及其制备方法 |
CN105288578A (zh) * | 2015-10-20 | 2016-02-03 | 宁波君瑞生物科技有限公司 | 一种具有缓解疲劳功能的制剂 |
CN106071723A (zh) * | 2016-06-29 | 2016-11-09 | 曹蕊 | 一种具有增强免疫力功能的健康食品及其制备方法 |
Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101002858A (zh) * | 2006-12-19 | 2007-07-25 | 戴甲木 | 一种具有增强免疫功效的组合物及其制备方法和其用途 |
CN101971980A (zh) * | 2010-07-26 | 2011-02-16 | 山西振东五和健康食品股份有限公司 | 基于恶性肿瘤化疗患者的营养粥 |
CN101971976A (zh) * | 2010-07-26 | 2011-02-16 | 山西振东五和健康食品股份有限公司 | 一种基于恶性肿瘤放疗患者的营养食品 |
CN101971981A (zh) * | 2010-07-26 | 2011-02-16 | 山西振东五和健康食品股份有限公司 | 用于恶性肿瘤患者术后调养的营养粥 |
CN101971979A (zh) * | 2010-07-26 | 2011-02-16 | 山西振东五和健康食品股份有限公司 | 一种用于恶性肿瘤患者术后调养的营养食品 |
CN103876208A (zh) * | 2014-03-19 | 2014-06-25 | 杨邱月 | 改善肿瘤患者术后免疫功能的保健汤及其制备方法 |
CN103908495A (zh) * | 2014-04-12 | 2014-07-09 | 陈欣 | 提高肿瘤患者术后免疫功能的中药组合物及制法 |
CN104116912A (zh) * | 2014-07-31 | 2014-10-29 | 边莉 | 一种用于肿瘤患者放化疗后康复的中药组合物 |
-
2014
- 2014-12-03 CN CN201410723136.5A patent/CN104489516A/zh active Pending
Patent Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101002858A (zh) * | 2006-12-19 | 2007-07-25 | 戴甲木 | 一种具有增强免疫功效的组合物及其制备方法和其用途 |
CN101971980A (zh) * | 2010-07-26 | 2011-02-16 | 山西振东五和健康食品股份有限公司 | 基于恶性肿瘤化疗患者的营养粥 |
CN101971976A (zh) * | 2010-07-26 | 2011-02-16 | 山西振东五和健康食品股份有限公司 | 一种基于恶性肿瘤放疗患者的营养食品 |
CN101971981A (zh) * | 2010-07-26 | 2011-02-16 | 山西振东五和健康食品股份有限公司 | 用于恶性肿瘤患者术后调养的营养粥 |
CN101971979A (zh) * | 2010-07-26 | 2011-02-16 | 山西振东五和健康食品股份有限公司 | 一种用于恶性肿瘤患者术后调养的营养食品 |
CN103876208A (zh) * | 2014-03-19 | 2014-06-25 | 杨邱月 | 改善肿瘤患者术后免疫功能的保健汤及其制备方法 |
CN103908495A (zh) * | 2014-04-12 | 2014-07-09 | 陈欣 | 提高肿瘤患者术后免疫功能的中药组合物及制法 |
CN104116912A (zh) * | 2014-07-31 | 2014-10-29 | 边莉 | 一种用于肿瘤患者放化疗后康复的中药组合物 |
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104825864A (zh) * | 2015-04-27 | 2015-08-12 | 陶俊荣 | 对放疗具有增效作用的保健药膳及制备方法 |
CN104872518A (zh) * | 2015-05-27 | 2015-09-02 | 济南方宇文化传媒有限公司 | 调理胃肠功能紊乱的粥品及其制备方法 |
CN104996526A (zh) * | 2015-08-06 | 2015-10-28 | 王永卿 | 适宜胃癌患者手术后服用的糕点及其制备方法 |
CN105053800A (zh) * | 2015-08-06 | 2015-11-18 | 王永卿 | 预防肿瘤放疗引起的骨髓抑制的养生粥及其制备方法 |
CN105106712A (zh) * | 2015-09-17 | 2015-12-02 | 王守花 | 一种帮助癌症患者术后恢复的营养粥及其制备方法 |
CN105105246A (zh) * | 2015-10-09 | 2015-12-02 | 张晓林 | 一种助于产妇补气养血的饮品及其制备方法 |
CN105288578A (zh) * | 2015-10-20 | 2016-02-03 | 宁波君瑞生物科技有限公司 | 一种具有缓解疲劳功能的制剂 |
CN106071723A (zh) * | 2016-06-29 | 2016-11-09 | 曹蕊 | 一种具有增强免疫力功能的健康食品及其制备方法 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104489516A (zh) | 提高肿瘤患者术后免疫功能的养生粥及制法 | |
CN103734424B (zh) | 一种苦荞减肥降脂通便茶及其制备方法 | |
CN105614667A (zh) | 一种养心富硒米粉及其制备方法 | |
WO2022143466A1 (zh) | 一种预防癌症药食同源植物中药组合物 | |
CN103689559A (zh) | 一种有助于改善胃肠功能的养生保健食品配方及其制备方法 | |
CN105232911A (zh) | 一种中药组合物 | |
CN102671163A (zh) | 一种治疗慢性胃炎的中药组合物 | |
CN113785981A (zh) | 一种养生的药食同源组合物及其制备方法 | |
CN104605387A (zh) | 减轻肿瘤患者术后放疗反应的营养药膳及制备方法 | |
CN105341226A (zh) | 一种具有通便润肠功效的保健茶及其制备方法 | |
CN115645491A (zh) | 一种补益脾肺的中药组合物及其制备方法 | |
CN104605372A (zh) | 一种基于恶性肿瘤放疗患者的营养药膳及制备方法 | |
CN104873926A (zh) | 治疗腹泻的中药制剂及其制备方法与应用 | |
CN104587126B (zh) | 一种治疗胃病的中药散剂 | |
CN107890521A (zh) | 一种护肝明目的中药组合物及其丸剂的制备方法 | |
KR20110025454A (ko) | 감기에 좋은 기능성 식품 및 이의 제조방법 | |
CN114748583A (zh) | 一种滋补养生的中药药酒 | |
CN105617268A (zh) | 一种治疗鳞屑角化型脚气的药物 | |
CN105394279A (zh) | 一种添加中药的降脂减肥茶及其制备方法 | |
CN104474342A (zh) | 一种适宜三高人群饮用的茶膏及其制备方法 | |
CN105394281A (zh) | 一种车前子通便润肠保健茶 | |
CN105105127A (zh) | 一种红果舒心粉多功能保健食品 | |
CN106804794A (zh) | 一种具有减肥降脂通便功效的保健茶 | |
CN109289017A (zh) | 用于清理血管和血液的组合物及制备方法 | |
CN101810751B (zh) | 一种治疗小儿肠系膜淋巴结发炎的中药制剂 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20150408 |
|
RJ01 | Rejection of invention patent application after publication |